Abstract:Hepatocellular carcinoma (HCC) is a highly vascularized tumor with frequent intrahepatic metastasis. Active angiogenesis and metastasis are responsible for rapid recurrence and poor survival of HCC. We previously found that microRNA-29b (miR-29b) down-regulation was significantly associated with poor recurrence-free survival of HCC patients. Therefore, the role of miR-29b in tumor angiogenesis, invasion, and metastasis was further investigated in this study using in vitro capillary tube formation and transwell assays, in vivo subcutaneous and orthotopic xenograft mouse models, and Matrigel plug assay, and human HCC samples. Both gain-and loss-of-function studies showed that miR-29b dramatically suppressed the ability of HCC cells to promote capillary tube formation of endothelial cells and to invade extracellular matrix gel in vitro. Using mouse models, we revealed that tumors derived from miR-29b-expressed HCC cells displayed significant reduction in microvessel density and in intrahepatic metastatic capacity compared with those from the control group. Subsequent investigations revealed that matrix metalloproteinase-2 (MMP-2) was a direct target of miR-29b. The blocking of MMP-2 by neutralizing antibody or RNA interference phenocopied the antiangiogenesis and antiinvasion effects of miR-29b, whereas introduction of MMP-2 antagonized the function of miR-29b. We further disclosed that miR-29b exerted its antiangiogenesis function, at least partly, by suppressing MMP-2 expression in tumor cells and, in turn, impairing vascular endothelial growth factor receptor 2-signaling in endothelial cells. Consistently, in human HCC tissues and mouse xenograft tumors miR-29b level was inversely correlated with MMP-2 expression, as well as tumor angiogenesis, venous invasion, and metastasis. Conclusion: miR-29b deregulation contributes to angiogenesis, invasion, and metastasis of HCC. Restoration of miR-29b represents a promising new strategy in anti-HCC therapy. (HEPATOLOGY 2011;54:1729-1740)

MiR-506 Suppresses Liver Cancer Angiogenesis Through Targeting Sphingosine Kinase 1 (SPHK1) Mrna

MiR-506 Suppresses Proliferation of Hepatoma Cells Through Targeting YAP Mrna 3′UTR

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

MicroRNA-503 Targets FGF2 and VEGFA and Inhibits Tumor Angiogenesis and Growth.

Up-regulation of Mir-506 Inhibits Cell Growth and Disrupt the Cell Cycle by Targeting YAP in Breast Cancer Cells.

Microrna-144-3p Suppresses Tumor Growth and Angiogenesis by Targeting Sgk3 in Hepatocellular Carcinoma

Mir-451 Acts As a Suppressor of Angiogenesis in Hepatocellular Carcinoma by Targeting the IL-6R-STAT3 Pathway.

MiR-302 A/b/c Suppresses Tumor Angiogenesis in Hepatocellular Carcinoma by Targeting MACC1.

Abstract 23: Microrna302-367 Sphingosine 1 Phosphate Receptor 1 Pathway Prevents Tumor Growth Via Restricting Angiogenesis and Enhancing Vascular Stability

MiR-126-3p Suppresses Tumor Metastasis and Angiogenesis of Hepatocellular Carcinoma by Targeting LRP6 and PIK3R2

Mir-124-3p Combined with Mir-506-3p Delay Hepatic Carcinogenesis Via Modulating Sirtuin 1

miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer

Downregulation of Mirna-638 Promotes Angiogenesis and Growth of Hepatocellular Carcinoma by Targeting VEGF

microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA

MicroRNA-138 Targets SP1 to Inhibit the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells

Down-regulation of Microrna-338-3p Promoted Angiogenesis in Hepatocellular Carcinoma.

MiR-503 Inhibits Hepatocellular Carcinoma Cell Growth Via Inhibition of Insulin-Like Growth Factor 1 Receptor.

Mir-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.

Microrna-29b Suppresses Tumor Angiogenesis, Invasion, and Metastasis by Regulating Matrix Metalloproteinase 2 Expression

Mir-206 Inhibits Cell Proliferation, Invasion, and Migration by Down-Regulating PTP1B in Hepatocellular Carcinoma.

MicroRNA-139 Inhibits Hepatocellular Carcinoma Cell Growth Through Down-Regulating Karyopherin Alpha 2